Business Wire

Deenova´s France Remarkable and Continued Success Extends to French overseas departments: winning Mayotte, GHPSO and I.N.I. Awards

Share

Deenova today disclosed that it expanded its market dominance in France with another net new UniHA competitive award for its D3 ACCED mechatronic solution at Centre Hospitalier de Mayotte in French overseas departments. Additionally, Deenova announced a new competitive tender win at GHPSO Creil & Senlis also for its market leading D3 ACCED mechatronic robot through its partnership with another premier hospital group, RESAH. Separately, Deenova is pleased to simultaneously report additional add-on sales of its unique ASTUS cabinets and D3 ACCED to existing Deenova customer Institute Nationale des Invalides in Paris, also through its UniHA partnership.

Loïc Bessin, Managing Director of Deenova in France stated: “Bringing together net new business tender wins at Centre Hospitalier de Mayotte and GHPSO Creil & Senlis for our D3 ACCED mechatronic solutions, while at the same time earning the trust of additional sales to previous Deenova ASTUS customers such as Institute Nationale des Invalides is steady evidence of Deenova France unparalleled success in our industry, undoubtedly showing the market a high level of reliable customer satisfaction in France.”

Christophe Jaffuel, Deenova Chief Commercial Officer, added: “A new milestone for Deenova is reached: expansion beyond the European continent, a great ongoing incentive for our sales teams. I am very appreciative for the important and yearly contribution that both UniHA and RESAH ongoing multi-year tender awards means to Deenova in France and now beyond, renewing its past commitment to Deenova market-leading Unit-Dose solutions. I look forward to continuing the outstanding cooperation with UniHA and RESAH in the near future.”

Centre Hospitalier de Mayotte, a public health establishment with 543 beds, is the only hospital in the overseas Department of Mayotte. It is located in the northern part of the Mozambique Channel in the Indian Ocean off the coast of Southeastern Africa. It provides both hospital care and out-patient care with 4 localized care and childbirth centers (North, Centre, South and Petite-Terre) of intermediate level, providing general consultations and a 24-hour medical service and 7 days a week.

GHPSO Creil & Senlis, located just 30 minutes from Paris CDG airport, offers a complete emergency service: Adult, Paediatric and Gyneco-obstetrics with 584 full hospital beds, 46 day hospitalization places, 21 haemodialysis stations, and on the other hand an offer in Follow-up and Rehabilitation Care (SSR) with 32 beds, in accommodation with 73 Long-Term Care Unit beds (USLD), 90 beds in an Accommodation Establishment for Dependent Elderly Persons (EHPAD) and 12 places in Alzheimer's day centre, i.e. a total of 858 beds. The SMUR unit intervenes at the request of the SAMU de l’Oise.

Institute Nationale des Invalides is placed under the supervision of the French Government Ministry of Defense and Veterans Affairs. It is responsible for welcoming veterans who are victims of severe handicaps linked to war wounds. It includes three complementary centers: the Pensioners’ Center, the Post-Traumatic Rehabilitation Center and the Center for Studies and Research on Equipment for the Handicapped. A total of 91 single rooms are fully equipped for patients in the Paris metropolitan area.

UniHA, the Union of Hospitals for Purchasing, is a cooperative of French public hospital buyers created in 2005 by the hospital staff themselves (32 CHU and 20 CH). As of 2022, 1.065 hospitals have joined the UniHA cooperative, with 115 GHT having conducted € 5.6 billion in group purchases in 2021. UniHA is one of the main European buyers in the field of health and one of the first national buyers, all sectors of activity combined. The essential challenge: to provide citizens with the best treatments available, to provide high-quality hospital services, and to preserve equal access to care.

RESAH is a public interest group (GIP) whose objective is to support the pooling and professionalisation of purchases from the health sector, public and private non-profit. It was created in 2007 to support the pooling of hospital purchases for the Ile-de-France region, in collaboration with Achat Hopital.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%. Please visit www.deenova.com for additional information on its market leading solutions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Contacts at Deenova:
Loïc Bessin, Christophe Jaffuel, Martina Buccianti
m.buccianti@deenova.com, +39 0523 785311

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Western Union Highlights ESG Progress and Recognitions Received29.6.2022 15:00:00 EEST | Press release

The Western Union Company (NYSE: WU) today released its 2021 Environmental, Social and Governance (ESG) Report, spotlighting the Company’s ongoing commitment to advancing its strategy and actions aligned with key ESG priorities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005138/en/ Western Union's 2021 ESG report spotlights the Company’s ongoing commitment to advancing its strategy and actions aligned with key ESG priorities.(Photo: Business Wire) “People are drawn to work for and do business with companies that make an impact,” said Devin McGranahan, Chief Executive Officer. “This year’s report shows that Western Union continues to make solid progress on our ESG journey, which in turn enables us to effect even more positive change in the communities we serve. I’m proud to work with colleagues who bring their best every day to improve the lives of our customers and communities around the world.” 2021 ESG Highlights

Pyramid Analytics Wins 2022 Ventana Research Digital Innovation Award in Analytics Category29.6.2022 15:00:00 EEST | Press release

Pyramid Analytics (Pyramid), a pioneering decision intelligence platform provider, today announced that the company won a 2022 Ventana Research Digital Innovation Award. The company’s Pyramid Decision Intelligence Platform was selected over finalists Qlik Active Intelligence and H2O AI Cloud in the Analytics category of the 15th edition of the respected analyst firm’s awards program. The award is given to the technology vendor that best exemplifies innovation in any use or application of analytics across business and/or IT. The Business Intelligence and Analytics segment of the global software market is highly competitive. There are an estimated 120 vendors in the space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005330/en/ Pyramid Analytics, a pioneering decision intelligence platform provider, won a 2022 Ventana Research Digital Innovation Award. The Pyramid Decision Intelligence Platform was selected over finali

GPS Announces New Senior Leadership Changes29.6.2022 14:14:00 EEST | Press release

Global Processing Services (GPS), a leading global payment technology platform, has today announced the promotion of Joanne Dewar to Vice Chair. Kevin Schultz has also been appointed as Chief Executive Officer, effective immediately. Joanne will maintain her position on the GPS board, where she will focus on the group’s growth and global profile, and continue to work alongside Chair, Gene Lockhart, in a newly created Office of the Chair. Joanne had been CEO at GPS for over four years and was instrumental in scaling the company and securing investment from arguably the most impressive consortium in the payments industry. Kevin brings a wealth of executive leadership experience in the payments and digital banking industry to his new role as CEO, where he will primarily focus on strategy and execution. Most recently, Kevin served as Fiserv’s Group President of the Digital Banking. Prior to Fiserv, Kevin served as President, Global Financial Services at First Data, following nearly 16 year

Velodyne Lidar CMO Sally Frykman Wins Woman of the Year Award at Sensors Converge Conference29.6.2022 13:48:00 EEST | Press release

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced its Chief Marketing Officer (CMO) Sally Frykman won the 2022 Woman of the Year award from Sensors Converge and Fierce Electronics. The Best of Sensors Awards recognize the best and most innovative products, technologies, teams and people in the sensors industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005178/en/ Sally Frykman, Chief Marketing Officer (CMO) at Velodyne Lidar, won the 2022 Woman of the Year award from Sensors Converge and Fierce Electronics. (Graphic: Velodyne Lidar) The Sensors Converge conference, which is taking place now in San Jose, covers sensors and electronics technologies and applications that are driving industry innovation. The conference’s awards, selected by a panel of industry experts, were presented yesterday at an event honoring the best in sensor technologies and the sensor ecosystem, people and companies. “Sally is very d

NICE Publishes Final Appraisal Document Recommending the Use of Adtralza® (tralokinumab) for Adult Patients With Moderate-to-Severe Atopic Dermatitis29.6.2022 13:47:00 EEST | Press release

LEO Pharma A/S, a global leader in medical dermatology, today announced that the National Institute for Health and Care Excellence (NICE) has issued a positive Final Appraisal Document (FAD) which recommends Adtralza® (tralokinumab) for use within NHS England and Wales. NICE recommends Adtralza for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients who are candidates for systemic therapy and have not responded to at least one systemic immunosuppressant, or these are not suitable.1 The NICE recommendation makes Adtralza the first and only recommended biologic for use within NHS England and Wales that specifically targets the interleukin (IL)-13 cytokine, a driver of AD signs and symptoms.1,2,3 AD affects approximately 3.5% of adults across Europe.7 “We are thrilled that today’s decision from NICE will help pave the way for atopic dermatitis patients in England and Wales to have access to Adtralza, as we continue to work alongside UK authorities to ensure reimbu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom